Related Experiment Video
Updated: May 7, 2026
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Cancer drug resistance: an evolving paradigm
Caitriona Holohan1, Sandra Van Schaeybroeck, Daniel B Longley
1Drug Resistance Group, Centre for Cancer Research and Cell Biology, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK.
Nature Reviews. Cancer
|September 25, 2013
Summary
Drug resistance in cancer is a major challenge. Understanding shared resistance mechanisms and utilizing new tools can help develop effective combination therapies and patient stratification strategies.
Area of Science:
- Oncology
- Cancer Research
- Pharmacology
Background:
- Drug resistance to chemotherapy and targeted therapies poses a significant challenge in cancer treatment.
- Mechanisms of resistance, including target alteration and pathway activation, are common across different therapy types.
- Ineffective induction of cell death is a hallmark of drug resistance.
Purpose of the Study:
- To explore the common mechanisms underlying resistance to chemotherapy and molecularly targeted therapies.
- To identify opportunities for overcoming drug resistance in cancer research.
- To highlight the potential of novel therapeutic strategies and biomarkers.
Main Methods:
- Analysis of shared resistance mechanisms in cancer.
- Review of advancements in preclinical models and high-throughput screening.
- Assessment of therapeutic drug combinations and predictive biomarkers.
Main Results:
- Identified common features in drug resistance mechanisms, such as target modification and altered cell death pathways.
- Highlighted the potential of combining different anticancer agents.
- Emphasized the role of predictive biomarkers for patient stratification.
Conclusions:
- Overcoming drug resistance requires a comprehensive understanding of its underlying mechanisms.
- Rational therapeutic drug combinations and predictive biomarkers are crucial for improving cancer treatment outcomes.
- Advancements in preclinical models and screening techniques offer new avenues for tackling drug resistance.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.